Medical Cannabis News


Canadian patients using cannabis to treat anxiety and depression experienced improved outcomes: study

CT scans



Researchers find "statistically significant improvements" between baseline and follow-up scores after initiating medical cannabis treatment.



Researchers from Harvest Medicine in Calgary suggest their recent findings support the view that using medical cannabis can help with treating anxiety and depression.

Investigators wanted to shed light on what impact medical cannabis has on outcomes for patients experiencing anxiety or depression.

Based on information from 7,362 patients who received their medical cannabis documentation and allotment from the Calgary clinic, researchers noted improved outcomes after initiating medical cannabis treatment and at the one-year follow-up.


Cantourage introduces Miracle Valley's Canadian medical high-THC cannabis flowers to German pharmacies

European medical cannabis leader Cantourage GmbH ("Cantourage") and Canada-based medical cannabis manufacturer Miracle Valley have entered a partnership that will see medical cannabis from British Columbia, Canada, brought to Germany.

Starting today, pharmacies and patients throughout Germany will have access to Miracle Valley's high-THC Mac 1 cultivar.


Victoria Cannabis Buyers Club meeting with Health Canada over dosage limits

Canada Flag

The Victoria Cannabis Buyers Club (VCBC) will be meeting with Health Canada on Monday to discuss dosage limits in cannabis products.

The club is currently facing about $6.5 million in fines, partially due to having higher doses in their products than approved by the organization.

VCBC, which is located on Johnson Street, has been providing cannabis products to patients with a confirmed diagnosis of a serious medical problem since 1996. Patients need a referral from a medical professional, giving them the option of cannabis over opioids for pain management.

It now has more than 8,500 patients fighting a number of conditions like diabetes, arthritis, and cancer.


City View receives Health Canada research license for product tasting of cannabis

Canadian Flag Lady


City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), a leading consumer packaged goods company focused on the development of cannabis-infused edibles is pleased to announce that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations.

This licence permits City View to conduct controlled human sensory (taste) trials of cannabis infused products. Activities granted as per Health Canada include, 1) to possess cannabis for the purpose of research and 2) to produce cannabis for the purpose of research. As an essential part of new product development, taste tests will lead to City View bringing to market high quality edibles that are reflective of market trends and consumer preference.


Alberta finds doctor guilty of professional misconduct over medical cannabis authorizations


A doctor in Alberta has been found guilty of professional misconduct for failing to follow the provincial college of physicians’ standards of practice for authorizing access to cannabis for medical purposes. 

The College of Physicians and Surgeons of Alberta (CPSA) found that Dr. Gaylord Wardell did not follow certain standards the College has in place for authorizing access to medical cannabis for someone. 

Although a four-person CPSA Hearing Tribunal found that several charges against the doctor were not proven, they did find one charge amounted to unprofessional conduct. 


Sproutly receives research license from Heath Canada


Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company"), is pleased to announce that the company's wholly-owned subsidiary, Toronto Herbal Remedies Inc. ("THR"), a licenced producer under the Cannabis Act, has received a research licence from Health Canada effective April 11, 2022. The licence allows THR to evaluate the ingredients produced by the proprietary APP technology and product formulations incorporating these ingredients.

"We are pleased to receive this license since we can now evaluate our proprietary extracts and the unique 2.0 product formulations before moving them forward to manufacturing and sale to Canadian consumers." said Arup Sen, CEO & Director.


NOSM University medical students create impactful video about cannabis use by teens

med student

Northern Ontario has the highest rates of cannabis dependence in high-school students across the province, according to the study Drug use among Ontario Students, published by the Canadian Mental Health Association in 2020.

When a group of fourth-year medical students at NOSM University learned these statistics, they felt compelled to educate preteens and teenagers ages 12-18 as part of their unique advocacy curriculum.

‚ÄúOur goal with this project was to create a captivating, information-packed¬†video to educate youth about cannabis¬†and share harm reduction strategies using reliable resources from the¬†Canadian Paediatric Society¬†(CPS) and the Government of Canada,‚ÄĚ says Kelsey Pitre, fourth-year NOSM University medical student.


This cannabis product was recalled by Health Canada due to a faulty package label


"The product label has incorrect cannabinoid activation values," Health Canada said.

Another day, another recall. Health Canada flagged and recalled a cannabis product on April 8 due to incorrect packaging label concerning an Emblem CBD product.

The affected product currently being recalled is the Emblem Cannabis CBD 100 Cannabis Extract (30mL).

For Montrealers who get their items at the SQDC, there isn't much to worry about, considering the product was "sold directly to clients registered for medical purposes," Health Canada said.


Agra Ventures applauds Health Canada's recent regulatory improvements

Canada cannabis


Agra Ventures Ltd, a growth-oriented and diversified company focused on the international cannabis industry, applauds Health Canada’s recently announced regulatory changes that will have the effect of streamlining the application process for cannabis processors to bring products to market more quickly. On March 31, 2022, Health Canada communicated that it would begin granting all standard and micro-class processing license holders sales authorizations for dried and fresh cannabis products during the initial licensing process. Therefore, licensees such as AGRA will no longer have to apply for an amendment in order to sell to wholesalers. The planned improvements to the licensing process are scheduled to go into effect on April 19, 2022.


The pandemic had little impact on Canada's legal cannabis sales

girl in store

The pandemic saw a boom in legal recreational cannabis sales across Canada. From March 2020 to February 2021, sales totaled $2.5 billion, double the $1.25 billion of the previous 12 months. Surveys likewise reported more cannabis users and more frequent usage in 2020 than the year before.

The increases were often blamed, despite a lack of evidence, on the COVID-19 pandemic and related societal disruptions. Many people were stuck alone at home and feeling stressed. Some commentators later walked back their claims after it became clear there was no data to support them, but the narrative still persists.

Although it’s a compelling anecdote, our new research found that the growth in cannabis sales was more likely from industry expansion, rather than the pandemic.


Subscribe to RSS - Medical Cannabis News